NCT00650221View on ClinicalTrials.gov

Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Therapeutic Equivalency
Interventions
DRUG

Pravastatin

Single-dose 80 mg immediate-release oral tablet

DRUG

Pravastatin

Single-dose 80 mg immediate-release tablet

Trial Locations (1)

M1L 4S4

Biovail Contract Research, Toronto

Sponsors

Collaborators (1)

Genpharm ULC
All Listed Sponsors
collaborator

Genpharm ULC

INDUSTRY

lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00650221 - Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects | Biotech Hunter | Biotech Hunter